Mirum Pharmaceuticals, Inc. (MIRM)
Total Valuation
MIRM has a market cap or net worth of $695.67 million. The enterprise value is $591.15 million.
Market Cap | 695.67M |
Enterprise Value | 591.15M |
Important Dates
The next earnings date is Thursday, August 4, 2022, after market close.
Estimated Earnings Date | Aug 4, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
MIRM has 31.94 million shares outstanding. The number of shares has increased by 3.96% in one year.
Shares Outstanding | 31.94M |
Shares Change (YoY) | +3.96% |
Shares Change (QoQ) | +2.49% |
Owned by Insiders (%) | 4.69% |
Owned by Institutions (%) | 87.57% |
Float | 13.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.72 |
PB Ratio | 6.39 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 18.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.24.
Current Ratio | 4.49 |
Quick Ratio | 7.17 |
Debt / Equity | 1.24 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -73.50%, which is considered low. The company has a ROIC of -22.20%.
Return on Equity (ROE) | -73.50% |
Return on Assets (ROA) | -26.50% |
Return on Capital (ROIC) | -22.20% |
Revenue Per Employee | $222,431 |
Profits Per Employee | -$486,542 |
Employee Count | 144 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, MIRM has paid $43,000 in taxes.
Income Tax | 43,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.03% in the last 52 weeks. The beta is 1.24, so MIRM's price volatility has been higher than the market average.
Beta (1Y) | 1.24 |
52-Week Price Change | +24.03% |
50-Day Moving Average | 22.14 |
200-Day Moving Average | 21.56 |
Average Volume (30 Days) | 235,280 |
Short Selling Information
The latest short interest is 1.65 million, so 5.16% of the outstanding shares have been sold short.
Short Interest | 1.65M |
Short % of Shares Out | 5.16% |
Short % of Float | 12.09% |
Short Ratio (days to cover) | 6.61 |
Income Statement
In the last 12 months, MIRM had revenue of $32.03 million and -70.06 million in losses. Earnings per share was -$2.29.
Revenue | 32.03M |
Gross Profit | 27.70M |
Operating Income | -158.54M |
Pretax Income | -70.02M |
Net Income | -70.06M |
EBITDA | -50.80M |
EBIT | -52.04M |
Earnings Per Share (EPS) | -$2.29 |
Balance Sheet
The company has $239.91 million in cash and $135.38 million in debt, giving a net cash position of $104.52 million or $3.27 per share.
Cash & Cash Equivalents | 239.91M |
Total Debt | 135.38M |
Net Cash | 104.52M |
Net Cash Per Share | $3.27 |
Book Value | 108.93M |
Book Value Per Share | 3.41 |
Working Capital | 120.72M |
Cash Flow
In the last 12 months, operating cash flow was -$147.22 million and capital expenditures $88.98 million, giving a free cash flow of -$58.24 million.
Operating Cash Flow | -147.22M |
Capital Expenditures | 88.98M |
Free Cash Flow | -58.24M |
FCF Per Share | n/a |
Margins
Gross margin is 86.49%, with operating and profit margins of -494.96% and -218.74%.
Gross Margin | 86.49% |
Operating Margin | -494.96% |
Pretax Margin | -218.60% |
Profit Margin | -218.74% |
EBITDA Margin | -158.61% |
EBIT Margin | -162.46% |
FCF Margin | -181.82% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -10.07% |
FCF Yield | -8.37% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.96% |
Shareholder Yield | -3.96% |
Analyst Forecast
The average price target for MIRM is $63.75, which is 192.70% higher than the current price. The consensus rating is "Buy".
Price Target | $63.75 |
Price Target Difference | 192.70% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |